TransMedics Group, Inc. (TMDX)

US — Healthcare Sector
Peers: INSP  NARI  INMD  PODD    SILK  LUNG  OFIX  TELA  CVRX  NPCE  DCTH  SWAV  PEN  MASI 

Automate Your Wheel Strategy on TMDX

With Tiblio's Option Bot, you can configure your own wheel strategy including TMDX - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol TMDX
  • Rev/Share 14.4782
  • Book/Share 7.8973
  • PB 16.1689
  • Debt/Equity 1.9467
  • CurrentRatio 9.0988
  • ROIC 0.0654

 

  • MktCap 4320237922.0
  • FreeCF/Share -1.875
  • PFCF -68.329
  • PE 87.9673
  • Debt/Assets 0.619
  • DivYield 0
  • ROE 0.2188

 

  • Rating B-
  • Score 2
  • Recommendation Sell
  • P/E Score 1
  • DCF Score 1
  • P/B Score 1
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
Downgrade TMDX JP Morgan Overweight Neutral $116 $75 Dec. 17, 2024
Initiation TMDX Robert W. Baird -- Outperform -- $200 Sept. 24, 2024
Initiation TMDX Needham -- Buy -- $208 Aug. 21, 2024

News

TransMedics Group, Inc. Class Action: Levi & Korsinsky Reminds TransMedics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 15, 2025 - TMDX
TMDX
Published: April 03, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / April 3, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transmedics-group-inc-lawsuit-submission-form-2?prid=140765&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news TransMedics Group, Inc. Class Action: Levi & Korsinsky Reminds TransMedics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 15, 2025 - TMDX
Class Action Filed Against TransMedics Group, Inc. (TMDX) - April 15, 2025 Deadline to Join - Contact Levi & Korsinsky
TMDX
Published: April 03, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / April 3, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transmedics-group-inc-lawsuit-submission-form-2?prid=140667&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news Class Action Filed Against TransMedics Group, Inc. (TMDX) - April 15, 2025 Deadline to Join - Contact Levi & Korsinsky
TMDX FRAUD ALERT: TransMedics Group 30% Stock Drop Triggers Class Action Lawsuit for Fraud – Investors are Notified to Contact BFA Law before April 15 (NASDAQ:TMDX)
TMDX
Published: April 03, 2025 by: GlobeNewsWire
Sentiment: Neutral

NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against TransMedics Group, Inc. (NASDAQ: TMDX) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in TransMedics , you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/transmedics-group-inc.

Read More
image for news TMDX FRAUD ALERT: TransMedics Group 30% Stock Drop Triggers Class Action Lawsuit for Fraud – Investors are Notified to Contact BFA Law before April 15 (NASDAQ:TMDX)
TMDX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that TransMedics Group, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit!
TMDX
Published: April 03, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / April 3, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against TransMedics Group, Inc. ("TransMedics" or "the Company") (NASDAQ:TMDX) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired TransMedics securities between February 3, 2022 and February 3, 2025, both dates inclusive (the "Class Period").

Read More
image for news TMDX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that TransMedics Group, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit!
TMDX LAWSUIT ALERT: The Gross Law Firm Notifies TransMedics Group, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
TMDX
Published: April 03, 2025 by: PRNewsWire
Sentiment: Neutral

NEW YORK , April 3, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of TransMedics Group, Inc. (NASDAQ: TMDX). Shareholders who purchased shares of TMDX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

Read More
image for news TMDX LAWSUIT ALERT: The Gross Law Firm Notifies TransMedics Group, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
TransMedics Group, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before April 15, 2025 to Discuss Your Rights -TMDX
TMDX
Published: April 02, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / April 2, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transmedics-group-inc-lawsuit-submission-form-2?prid=140549&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news TransMedics Group, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before April 15, 2025 to Discuss Your Rights -TMDX
Scott+Scott Attorneys at Law LLP Files Securities Class Action Against TransMedics Group, Inc. (NASDAQ: TMDX)
TMDX
Published: April 02, 2025 by: GlobeNewsWire
Sentiment: Neutral

NEW YORK, April 02, 2025 (GLOBE NEWSWIRE) -- Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international shareholder and consumer rights litigation firm, has filed a securities class action lawsuit in the United States District Court for the District of Massachusetts against TransMedics Group, Inc. (“TransMedics Group” or the “Company”) (NASDAQ: TMDX), and certain of its former and current officers and/or directors (collectively, “Defendants”). The Class Action asserts claims under §§10(b) and 20(a) of the Securities Exchange Act of 1934 (15 U.S.C. §§78j(b) and 78t(a)) and U.S. Securities and Exchange Commission Rule 10b-5 promulgated thereunder (17 C.F.R. §240.10b-5) on behalf of …

Read More
image for news Scott+Scott Attorneys at Law LLP Files Securities Class Action Against TransMedics Group, Inc. (NASDAQ: TMDX)
TransMedics Group (NASDAQ: TMDX) Deadline Approaching: Berger Montague Advises Investors of Deadline in Securities Fraud Lawsuit
TMDX
Published: April 02, 2025 by: GlobeNewsWire
Sentiment: Neutral

PHILADELPHIA, April 02, 2025 (GLOBE NEWSWIRE) -- Berger Montague PC advises investors that a securities class action lawsuit has been filed against TransMedics Group, Inc. (“TransMedics” or the “Company”) (NASDAQ: TMDX) on behalf of purchasers of TransMedics securities between February 28, 2023 through January 10, 2025, inclusive (the “Class Period”).

Read More
image for news TransMedics Group (NASDAQ: TMDX) Deadline Approaching: Berger Montague Advises Investors of Deadline in Securities Fraud Lawsuit
Investors who lost money on TransMedics Group, Inc.(TMDX) Should Contact Levi & Korsinsky about Pending Class Action - TMDX
TMDX
Published: April 02, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / April 2, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transmedics-group-inc-lawsuit-submission-form-2?prid=140457&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news Investors who lost money on TransMedics Group, Inc.(TMDX) Should Contact Levi & Korsinsky about Pending Class Action - TMDX
TransMedics Group (TMDX) Shares Down 60% From Class Period High, Class-Action Suit Pending – Hagens Berman
TMDX
Published: April 02, 2025 by: GlobeNewsWire
Sentiment: Neutral

TMDX Investors with Losses Encouraged to Contact the Firm Before Apr. 15th Deadline TMDX Investors with Losses Encouraged to Contact the Firm Before Apr. 15th Deadline

Read More
image for news TransMedics Group (TMDX) Shares Down 60% From Class Period High, Class-Action Suit Pending – Hagens Berman
TMDX Investors Have Opportunity to Lead TransMedics Group, Inc. Securities Fraud Lawsuit with the Schall Law Firm
TMDX
Published: April 02, 2025 by: PRNewsWire
Sentiment: Neutral

LOS ANGELES , April 2, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against TransMedics Group, Inc. ("TransMedics" or "the Company") (NASDAQ: TMDX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 28, 2023 and January 10, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before April 15, 2025.

Read More
image for news TMDX Investors Have Opportunity to Lead TransMedics Group, Inc. Securities Fraud Lawsuit with the Schall Law Firm
TMDX LAWSUIT ALERT: Levi & Korsinsky Notifies TransMedics Group, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
TMDX
Published: April 01, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / April 1, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transmedics-group-inc-lawsuit-submission-form-2?prid=140243&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news TMDX LAWSUIT ALERT: Levi & Korsinsky Notifies TransMedics Group, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
Contact Levi & Korsinsky by April 15, 2025 Deadline to Join Class Action Against TransMedics Group, Inc. (TMDX)
TMDX
Published: April 01, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / April 1, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transmedics-group-inc-lawsuit-submission-form-2?prid=140204&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news Contact Levi & Korsinsky by April 15, 2025 Deadline to Join Class Action Against TransMedics Group, Inc. (TMDX)
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 15, 2025 in TransMedics Lawsuit – TMDX
TMDX
Published: April 01, 2025 by: GlobeNewsWire
Sentiment: Neutral

NEW YORK, April 01, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in TransMedics Group, Inc. ("TransMedics" or the "Company") (NASDAQ: TMDX) of a class action securities lawsuit.

Read More
image for news Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 15, 2025 in TransMedics Lawsuit – TMDX
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in TransMedics Group, Inc of Class Action Lawsuit and Upcoming Deadlines - TMDX
TMDX
Published: April 01, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK CITY, NY / ACCESS Newswire / April 1, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against TransMedics Group, Inc ("TransMedics" or the "Company") (NASDAQ:TMDX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

Read More
image for news INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in TransMedics Group, Inc of Class Action Lawsuit and Upcoming Deadlines - TMDX
TransMedics Group, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - TMDX
TMDX
Published: March 31, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / March 31, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transmedics-group-inc-lawsuit-submission-form-2?prid=139984&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news TransMedics Group, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - TMDX
TransMedics Group, Inc. Class Action: Levi & Korsinsky Reminds TransMedics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 15, 2025 - TMDX
TMDX
Published: March 28, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / March 28, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transmedics-group-inc-lawsuit-submission-form-2?prid=139547&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news TransMedics Group, Inc. Class Action: Levi & Korsinsky Reminds TransMedics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 15, 2025 - TMDX
TransMedics Group (TMDX) Shares Down 60% From Class Period High, Class-Action Suit Pending – Hagens Berman
TMDX
Published: March 28, 2025 by: GlobeNewsWire
Sentiment: Neutral

SAN FRANCISCO, March 28, 2025 (GLOBE NEWSWIRE) -- A class-action lawsuit has been filed against the medical technology company, which specializes in organ transplant therapy, alleging that the company and certain executives engaged in fraudulent practices and concealed safety issues. The suit, captioned Jewik v.

Read More
image for news TransMedics Group (TMDX) Shares Down 60% From Class Period High, Class-Action Suit Pending – Hagens Berman
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in TransMedics Group, Inc of Class Action Lawsuit and Upcoming Deadlines - TMDX
TMDX
Published: March 28, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / March 28, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against TransMedics Group, Inc ("TransMedics" or the "Company") (NASDAQ:TMDX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

Read More
image for news INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in TransMedics Group, Inc of Class Action Lawsuit and Upcoming Deadlines - TMDX
Class Action Filed Against TransMedics Group, Inc. (TMDX) - April 15, 2025 Deadline to Join – Contact Levi & Korsinsky
TMDX
Published: March 27, 2025 by: GlobeNewsWire
Sentiment: Neutral

NEW YORK, March 27, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in TransMedics Group, Inc. ("TransMedics" or the "Company") (NASDAQ: TMDX) of a class action securities lawsuit.

Read More
image for news Class Action Filed Against TransMedics Group, Inc. (TMDX) - April 15, 2025 Deadline to Join – Contact Levi & Korsinsky
Class Action Filed Against TransMedics Group, Inc. (TMDX) Seeking Recovery for Investors - Contact Levi & Korsinsky
TMDX
Published: March 27, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / March 27, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transmedics-group-inc-lawsuit-submission-form-2?prid=139169&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news Class Action Filed Against TransMedics Group, Inc. (TMDX) Seeking Recovery for Investors - Contact Levi & Korsinsky
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in TransMedics Group, Inc of Class Action Lawsuit and Upcoming Deadlines - TMDX
TMDX
Published: March 27, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK CITY, NY / ACCESS Newswire / March 27, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against TransMedics Group, Inc ("TransMedics" or the "Company") (NASDAQ:TMDX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

Read More
image for news INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in TransMedics Group, Inc of Class Action Lawsuit and Upcoming Deadlines - TMDX
TMDX STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that TransMedics Group, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
TMDX
Published: March 27, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / March 27, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against TransMedics Group, Inc. ("TransMedics" or "the Company") (NASDAQ:TMDX) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired TransMedics securities between February 3, 2022 and February 3, 2025, both dates inclusive (the "Class Period").

Read More
image for news TMDX STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that TransMedics Group, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
April 15, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against TMDX
TMDX
Published: March 27, 2025 by: PRNewsWire
Sentiment: Neutral

NEW YORK , March 27, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of TransMedics Group, Inc. (NASDAQ: TMDX). Shareholders who purchased shares of TMDX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

Read More
image for news April 15, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against TMDX
Lost Money on TransMedics Group, Inc. (TMDX)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
TMDX
Published: March 26, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / March 26, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transmedics-group-inc-lawsuit-submission-form-2?prid=139024&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news Lost Money on TransMedics Group, Inc. (TMDX)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
Kirby McInerney LLP Urges Investors in TransMedics Group, Inc. (TMDX) to Inquire About Their Rights in Class Action Lawsuit
TMDX
Published: March 26, 2025 by: GlobeNewsWire
Sentiment: Neutral

NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the District of Massachusetts on behalf of those who acquired TransMedics Group, Inc. (“TransMedics” or the “Company”) (NASDAQ:TMDX) securities during the period from February 28, 2023, through January 10, 2025 (“the Class Period”). Investors have until April 15, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Read More
image for news Kirby McInerney LLP Urges Investors in TransMedics Group, Inc. (TMDX) to Inquire About Their Rights in Class Action Lawsuit
ROSEN, SKILLED INVESTOR COUNSEL, Encourages TransMedics Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action Commenced by the Firm - TMDX
TMDX
Published: March 26, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / March 26, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of TransMedics Group, Inc. (NASDAQ:TMDX) between February 28, 2023 and January 10, 2025, both dates inclusive (the "Class Period"), of the important April 15, 2025 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased TransMedics securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Read More
image for news ROSEN, SKILLED INVESTOR COUNSEL, Encourages TransMedics Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action Commenced by the Firm - TMDX
Class Action Filed Against TransMedics Group, Inc. (TMDX) - April 15, 2025 Deadline to Join – Contact Levi & Korsinsky
TMDX
Published: March 26, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / March 26, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transmedics-group-inc-lawsuit-submission-form-2?prid=138986&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news Class Action Filed Against TransMedics Group, Inc. (TMDX) - April 15, 2025 Deadline to Join – Contact Levi & Korsinsky
TMDX Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against TransMedics Group, Inc. (TMDX)
TMDX
Published: March 26, 2025 by: PRNewsWire
Sentiment: Neutral

RADNOR, Pa. , March 26, 2025 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against TransMedics Group, Inc. ("TransMedics") (NASDAQ: TMDX) on behalf of those who purchased or otherwise acquired TransMedics securities between February 28, 2023, and January 10, 2025, inclusive (the "Class Period").

Read More
image for news TMDX Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against TransMedics Group, Inc. (TMDX)
TMDX INVESTOR NOTICE: TransMedics Group, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit
TMDX
Published: March 26, 2025 by: PRNewsWire
Sentiment: Neutral

SAN DIEGO , March 26, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of TransMedics Group, Inc. (NASDAQ: TMDX) publicly traded securities between February 28, 2023 and January 10, 2025, inclusive (the "Class Period"), have until Tuesday, April 15, 2025 to seek appointment as lead plaintiff of the TransMedics class action lawsuit. Captioned Jewik v.

Read More
image for news TMDX INVESTOR NOTICE: TransMedics Group, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit

About TransMedics Group, Inc. (TMDX)

  • IPO Date 2019-05-02
  • Website https://www.transmedics.com
  • Industry Medical - Devices
  • CEO Dr. Waleed H. Hassanein M.D.
  • Employees 728

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for extracorporeal perfusion and preservation of donor hearts; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.